Tuesday, November 21, 2006

Autism

From the NYTimes:
The research emphasis of the act is appropriate, given how little is still known about the causes and the physiology of autism spectrum disorders, as well as the means by which medical treatments can reduce autism’s severity if applied early enough. Basic questions like whether the frequency of childhood vaccines today contributes to autism are still unresolved.

As parents of a child facing these challenges, we applaud those lawmakers and fellow parents who have done so much to promote this and other initiatives. But research is not enough. We as a nation must also begin to focus seriously on treating those children who are already afflicted. At present, we are failing miserably to do so.
This Opinion piece explains briefly how expensive quality intervention can be (more than $50,000 a year for preschool children), but also how the chances for improvement are increased dramatically with it.
Studies now show that 40 percent to 50 percent of toddlers undergoing intensive Applied Behavior Analysis, one of the best-known methods, can be mainstreamed in regular classrooms without personal aides by the time they reach school age. (The figure is close to zero for children not given special care.) Most of the other 50 percent to 60 percent make notable progress too.
What makes this even more of a no-brainer is that it isn't just the humane thing to do, it also seems to be the efficient thing to do. By investing money up front to help improve the lives of these children, you decrease the long term costs associated with their care for the rest of their life. The authors are right, more funding for research is good, but not enough. Here are our options:
Our options range from mandating that insurance companies cover therapies documented to work, to trumpeting the example of places that do provide coverage in the hope others will follow, to expanding autism Medicaid waivers.

No comments: